Through PPI construction, we identified several genes, including mRNA (CAP2, SLC22A3), miRNA (miR-9985, miR-27, miR-548), and TFs (CEBPA), involved in the prognosis mechanism of pancreatic cancer. This evidence concerns the gene SLC22A3 and familial pancreatic carcinoma.